Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Sangamo BioSciences, Inc. (SGMO)

« Back to company index

SGMO Chatter Timeline

Stock Ticker for SGMO

Most Active Tweeters for SGMO

UserTweets
@_B_I_O_T_E_C_H_ 15
@mchilberg 7
@Tickeron 6
@MitchellReed09 6
@Ba4Saso 5

Recent Tweets for SGMO

YuZhu4 @YuZhu4
RT @mchilberg: Another new $SGMO req for CNS. That makes 4 open reqs for ZFP-TF to go with 2 new hires in past 3 wks. Too much activity f…
January 25th 2022, 7:01pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
RT @Biotech2050: @SangamoTx All $SGMO holders have donated their blood ? and have none left. Have you not seen the ? spilled on the floor,…
January 25th 2022, 6:01pm
mchilberg @mchilberg
Another new $SGMO req for CNS. That makes 4 open reqs for ZFP-TF to go with 2 new hires in past 3 wks. Too much a… https://t.co/dPCFKndWsF
January 25th 2022, 5:01pm
Biotech2050 @Biotech2050
@SangamoTx All $SGMO holders have donated their blood ? and have none left. Have you not seen the ? spilled on the… https://t.co/IJmRa2uo0W
January 25th 2022, 5:01pm
Gambiste1 @Gambiste1
RT @SweepCastApp: SweepCast alerted: $SGMO with Unusual Options Activity Alerted on $11 PUT Expiring: 05-20-2022 worth 28K? |? Check out ht…
January 25th 2022, 7:01am
SweepCastApp @SweepCastApp
SweepCast alerted: $SGMO with Unusual Options Activity Alerted on $11 PUT Expiring: 05-20-2022 worth 28K? |? Check… https://t.co/1bjwxyWKXt
January 25th 2022, 7:01am
SweepCastApp @SweepCastApp
$SGMO Sangamo Therapeutics Option Alert: May 20 $11 Puts at the Bid: 50 vs 0 OI; Earnings 2/23 After Close [est] ?… https://t.co/0ZhgUR7OqS
January 25th 2022, 12:01am
mchilberg @mchilberg
Market is trying to bounce after heavy hit this morning. Comparison - $CRSP still down 5% - $SGMO just recovered days losses 9/
January 24th 2022, 7:01pm
MitchellReed09 @MitchellReed09
RT @mchilberg: $SGMO added a number of new open reqs in techops recently. Likely due to SCD ownership, TX200, Fabry escalation and possibl…
January 24th 2022, 5:01pm
mchilberg @mchilberg
$SGMO added a number of new open reqs in techops recently. Likely due to SCD ownership, TX200, Fabry escalation an… https://t.co/9lyrpunBtY
January 24th 2022, 5:01pm
SweepCastApp @SweepCastApp
$SGMO Sangamo Therapeutics Option Alert: Fri $9 Puts at the Ask: 100 vs 364 OI; Earnings 2/23 After Close [est] ? |… https://t.co/XNp5Y8Uq9T
January 24th 2022, 5:01pm
Ba4Saso @Ba4Saso
$SGMO Waiting for Buy signal. Chart by https://t.co/z6vAd7dl0q https://t.co/95vls1cTJD
January 24th 2022, 5:01pm
ShortAlgoKing @ShortAlgoKing
$SGMO Awaiting Buy Signal. Chart by https://t.co/qchl9O5K2n https://t.co/L0RHBsAO9u
January 24th 2022, 11:01am
RTLeenay @RTLeenay
@labratorytenant @NatHarooni … protein engineering rather than just swapping in and out an RNA. I mean $SGMO has ha… https://t.co/j016HpG54C
January 24th 2022, 2:01am
Tickeron @Tickeron
$SGMO's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/hJaYnrOtJi
January 23rd 2022, 3:01pm
Ba4Saso @Ba4Saso
$SGMO Watching for Buy Signal. Chart by https://t.co/z6vAd7dl0q https://t.co/fx4tufWMGj
January 23rd 2022, 12:01pm
MitchellReed09 @MitchellReed09
RT @MarcJacksonLA: $SGMO Sangamo Therapeutics Given Consensus Rating of "Buy" by Brokerages | $18.40 Average PT https://t.co/NKb5pRLCDo htt…
January 23rd 2022, 3:01am
MarcJacksonLA @MarcJacksonLA
$SGMO Sangamo Therapeutics Given Consensus Rating of "Buy" by Brokerages | $18.40 Average PT https://t.co/NKb5pRLCDo https://t.co/WzzvWd9DTb
January 22nd 2022, 10:01pm
Tickeron @Tickeron
$SGMO's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds f… https://t.co/PbBZOAEK8Q
January 22nd 2022, 7:01pm
mattyjc @mattyjc
@michaeldurnin1 Agree! And now Fabry is going to be just as, if not more valuable than Heme A to $SGMO. I suspect… https://t.co/KYfVrpsD7d
January 22nd 2022, 1:01pm
mattyjc @mattyjc
@michaeldurnin1 I’ve had my $SGMO shares so long I’d probably watch them go to zero before I’d sell. Didn’t sell an… https://t.co/kpeJrPjjxS
January 22nd 2022, 12:01pm
michaeldurnin1 @michaeldurnin1
@mattyjc I am in $RBLX and $SGMO , and I think I’ll leave it there for the next 6months think Both are excellent 1-… https://t.co/odg6yI584y
January 22nd 2022, 9:01am
Biotech2050 @Biotech2050
RT @_B_I_O_T_E_C_H_: $SGMO #BASE #EDITING Nuclear and mitochondrial DNA editing with #zinc #finger deaminases ZFDs with enhanced efficiency…
January 22nd 2022, 9:01am
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
$SGMO #BASE #EDITING Nuclear and mitochondrial DNA editing with #zinc #finger deaminases ZFDs with enhanced efficie… https://t.co/eCdqQBlWGH
January 22nd 2022, 9:01am
QuantchaIdeas @QuantchaIdeas
StockTwits Trending Alert: Trading recent interest in SANGAMO THERAPEUTICS INC. COMMON STOCK $SGMO https://t.co/zrqkODtfXp
January 22nd 2022, 5:01am
retailbiotech @retailbiotech
$SGMO best gene therapy and gene edited.
January 21st 2022, 2:01pm
michaeldurnin1 @michaeldurnin1
@mchilberg @Biotech2050 Good news , so that means $SGMO down 10% today lol ?
January 21st 2022, 2:01pm
smargach @smargach
@_B_I_O_T_E_C_H_ The crack IR team at $sgmo hard at work.
January 20th 2022, 3:01pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
RT @_B_I_O_T_E_C_H_: $SGMO Sangamo CEO says preclinical studies moving forward 'beautifully' https://t.co/xarOmB2idB
January 20th 2022, 3:01pm
inoritrade @inoritrade
$SGMO Waiting for BUY signal on SGMO with https://t.co/WBARPaspdC https://t.co/bKvjRYF1hW
January 20th 2022, 3:01pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
RT @_B_I_O_T_E_C_H_: $SGMO Sangamo COO sees 'important catalysts' over next 12 month #agency will be #lifted #shortly and we will continu…
January 20th 2022, 2:01pm
B_rizzle87 @B_rizzle87
@_B_I_O_T_E_C_H_ It is illegal for $SGMO stock to go up.
January 20th 2022, 12:01pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
$SGMO Sangamo COO sees 'important catalysts' over next 12 month #agency will be #lifted #shortly and we will cont… https://t.co/PrlRpQMhcF
January 20th 2022, 12:01pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
$SGMO Sangamo CEO says preclinical studies moving forward 'beautifully' https://t.co/xarOmB2idB
January 20th 2022, 12:01pm
MitchellReed09 @MitchellReed09
RT @InvestorVillage: Trending: $SGMO COO Mark McClung says company anticipates clinical hold on Hemophilia A trial (in partnership with $P…
January 19th 2022, 9:01pm
maximtrade134 @maximtrade134
RT @newsinthemarket: Clinical hold on Hemophilia A program should be lifted soon, Sangamo COO says $SGMO
January 19th 2022, 9:01pm
Gambiste1 @Gambiste1
RT @_B_I_O_T_E_C_H_: Meet Sangamo: Fly exclusive interview with $SGMO CEO Sandy Macrae, COO Mark McClung https://t.co/28zNsPuMiJ
January 19th 2022, 9:01pm
EVgirl66 @EVgirl66
RT @_B_I_O_T_E_C_H_: FLY: $PFE $SGMO Clinical hold on Hemophilia A program should be lifted soon, Sangamo COO says
January 19th 2022, 9:01pm
InvestorVillage @InvestorVillage
Trending: $SGMO COO Mark McClung says company anticipates clinical hold on Hemophilia A trial (in partnership with… https://t.co/SXB5xqoM1X
January 19th 2022, 8:01pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
Meet Sangamo: Fly exclusive interview with $SGMO CEO Sandy Macrae, COO Mark McClung https://t.co/28zNsPuMiJ
January 19th 2022, 7:01pm
BioWino @BioWino
petri dish say what? $sgmo https://t.co/PwdxdIv2Ho
January 19th 2022, 7:01pm
vtmtrading @vtmtrading
Sangamo CEO says success in CAR-TREG space more 'than just science' $SGMO
January 19th 2022, 6:01pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
RT @newsinthemarket: Sangamo 'an unusual company' with deep portfolio, CEO says $SGMO
January 19th 2022, 6:01pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
FLY: $PFE $SGMO Clinical hold on Hemophilia A program should be lifted soon, Sangamo COO says
January 19th 2022, 6:01pm
newsinthemarket @newsinthemarket
Success in CAR-TREG more than just science, Sangamo CEO says $SGMO
January 19th 2022, 6:01pm
newsinthemarket @newsinthemarket
Clinical hold on Hemophilia A program should be lifted soon, Sangamo COO says $SGMO
January 19th 2022, 6:01pm
newsinthemarket @newsinthemarket
Sangamo expects to dose first patients by mid-2022 in TX200 trial, COO says $SGMO
January 19th 2022, 6:01pm
newsinthemarket @newsinthemarket
Sangamo 'an unusual company' with deep portfolio, CEO says $SGMO
January 19th 2022, 6:01pm
BioWino @BioWino
RT @algobotnews: Sangamo 'an unusual company' with deep portfolio, CEO says $SGMO
January 19th 2022, 6:01pm
BioWino @BioWino
RT @algobotnews: Clinical hold on Hemophilia A program should be lifted soon, Sangamo COO says $SGMO
January 19th 2022, 6:01pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2022. All rights reserved.